Markets:

Overview

News

Currencies

International

Treasuries

Arcus Biosciences, Inc. Common Stock (NY:RCUS)

22.70 +0.30 (+1.36%)

Streaming Delayed Price Updated: 10:35 AM EDT, Apr 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Arcus Biosciences, Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >

Urban Outfitters, Toll Brothers And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session ↗

August 23, 2023

U.S. stock futures traded higher this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Preview: Arcus Biosciences's Earnings ↗

August 04, 2023

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

July 31, 2023

Via Benzinga

Over $59M Bet On This Communication Services Stock? Check Out These 3 Stocks Insiders Are Buying ↗

July 03, 2023

Although US stocks closed higher on Friday, there were a few notable insider trades.

Via Benzinga

BJ's Wholesale Club, Verint Systems And 2 Other Stocks Insiders Are Selling ↗

June 27, 2023

The S&P 500 closed lower on Monday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Citigroup Maintains Buy Rating for Arcus Biosciences: Here's What You Need To Know ↗

May 26, 2023

Via Benzinga

Earnings Preview For Arcus Biosciences ↗

May 08, 2023

Via Benzinga

Arcus Biosciences Earnings Perspective: Return On Capital Employed ↗

March 06, 2023

Via Benzinga

Where Arcus Biosciences Stands With Analysts ↗

December 20, 2022

Via Benzinga

Stock Market Rally Broadens Out; Apple Unveils Vision Pro, SEC Sues Binance, Coinbase: Weekly Review ↗

June 09, 2023

The Nasdaq held near 52-week highs while small caps ramped up.

Via Investor's Business Daily

ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Crashes ↗

June 05, 2023

ImmunoGen and Day One gained Monday on their updates at a cancer treatment conference.

Via Investor's Business Daily

3 Undervalued Biotech Stocks to Buy Before They Blast Off ↗

June 02, 2023

Fundamental analysis makes these three undervalued biotech stocks to buy plus they have other catalysts that make them compelling.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

May 29, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 26, 2023

Via Benzinga

Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 26, 2023

Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool.

Via Benzinga

Booz Allen Hamilton, Workday, Marvell Technology And Other Big Stocks Moving Higher On Friday ↗

May 26, 2023

U.S. stocks traded higher, with the Dow Jones gaining over 300 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Arcus Biosciences Soars On Roche's 'Meaningful' Results In A New Cancer Drug Class ↗

May 26, 2023

Roche tested its treatment in patients with liver cancer and found "meaningful" results.

Via Investor's Business Daily

Nasdaq Rises 1%; US Goods Trade Gap Widens In April ↗

May 26, 2023

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 1% on Friday. Following the market opening Friday, the Dow traded up 0.87% to 33,050.97 while the NASDAQ rose 1.06% to...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 26, 2023

Via Benzinga

Why Gap Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗

May 26, 2023

Gainers Oncorus, Inc. (NASDAQ: ONCR) shares rose 90% to $0.38 in pre-market trading after dropping around 17% on Thursday. Oncorus recently posted a narrower-than-expected quarterly loss.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

May 26, 2023

It's time for another dive into the biggest pre-market stock movers as we check out what's happening this morning on Friday!

Via InvestorPlace

3 Analyst Upgrades That Smart Investors Won’t Ignore ↗

May 17, 2023

In many cases, analyst upgrades can point investors to opportunities like the ones in the stocks on this list.

Via InvestorPlace

Can The No. 1 Pharma Stock, Merck, Continue Its Blazing Run In 2023? ↗

January 05, 2023

Merck has a number of efforts in the works to help avoid a Keytruda generics pitfall.

Via Investor's Business Daily

Stock Market Falls Sharply Again As Tesla Dives, Micron Hits Chips; Nike, FedEx Strong: Weekly Review ↗

December 23, 2022

The market uptrend is under pressure.

Via Investor's Business Daily

Earnings Scheduled For February 28, 2023 ↗

February 28, 2023

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.

Via Benzinga

Gilead Sciences (GILD) Stock Falls on Lung Cancer Drug Data ↗

December 20, 2022

Although Gilead Sciences produced meaningful results regarding a lung cancer drug test, the competitive shortfall hurt GILD stock.

Via InvestorPlace

Dow Jumps 150 Points; Crude Oil Rises 1% ↗

December 20, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 150 points on Tuesday.

Via Benzinga

Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session ↗

December 20, 2022

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 20, 2022

Via Benzinga

Nasdaq Edges Lower; Gold Rises 1.5% ↗

December 20, 2022

U.S. stocks traded mixed midway through trading, with the S&P 500 and the Nasdaq Composite moving lower on Tuesday.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Arcus Biosciences, Inc. Common Stock (NY:RCUS)

Headline News about Arcus Biosciences, Inc. Common Stock

Starting at $3.75/week.

Subscribe Today